Chiron Real Estate Inc. (NYSE: XRN) is a Real Estate company (REIT - Healthcare Facilities) with a market capitalization of $342M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Chiron Real Estate Inc. had a Maz Rating of 4.74 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Valuation (4.47), more attractively valued than most of its sector; its weakest was Momentum (3.70), above most of its sector. The other factors: Growth 4.12 (above most of its sector); Profitability 3.92 (above most of its sector); Financial Health 3.89 (above most of its sector). The current rating is for members: log in to see it.
At $25.80, Chiron Real Estate Inc. trades at 7.0x trailing earnings, 2.2x sales and 0.5x book value, with an EV/EBITDA of 6.4. Over the last twelve months it generated about $157M of revenue and $49M of net income. It runs a gross margin of -4.5%, an operating margin of 19.4% and a net margin of 36.6%. It shows return on equity of 9.9%, return on invested capital of 3.7% and a free cash flow yield of -61.2%. On the balance sheet: a debt-to-equity ratio of 1.03 and a current ratio of 59.65. Over the past 52 weeks the share price ranged from $25.70 to $38.65, with a beta of 1.13.
Chiron Real Estate Inc. pays a dividend yielding 8.92%, with 75% of earnings paid out.
5 Wall Street analyst ratings cover the stock: 2 Buy and 3 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.